Eleftherios
Eleftherios Adamopoulos, Gurnee, IL US
Patent application number | Description | Published |
---|---|---|
20150086472 | PROCESS FOR CATALYTIC REFORMING - One exemplary embodiment can be a process for catalytic reforming The process can include catalytically reforming a hydrocarbon feed in a reaction zone, obtaining an effluent stream having hydrogen and hydrocarbons from the reaction zone, obtaining from at least a portion of the effluent stream a waste hydrocarbon stream from an adsorption zone, passing at least a portion of the waste hydrocarbon stream as a feed stream across a feed side of a membrane having the feed side and a permeate side, and being selective for hydrogen over one or more C1-C6 hydrocarbons, and withdrawing from the permeate side a permeate stream enriched in hydrogen compared with a residue stream withdrawn from the feed side. | 03-26-2015 |
20150375159 | PRESSURE SWING ADSORPTION PROCESSES AND SYSTEMS FOR RECOVERY OF HYDROGEN AND C2+ HYDROCARBONS - The invention involves a process for treating a gas stream from a hydroprocessor that contains hydrogen, methane and C | 12-31-2015 |
20160115099 | METHODS AND APPARATUSES FOR REFORMING OF HYDROCARBONS INCLUDING RECOVERY OF PRODUCTS USING A RECOVERY ZONE, A PRESSURE SWING ADSORPTION ZONE, AND A MEMBRANE SEPARATION ZONE - Embodiments of apparatuses and methods for reforming of hydrocarbons including recovery of products are provided. In one example, a method comprises separating a reforming-zone effluent into a net gas phase stream and a liquid phase hydrocarbon stream. The net gas phase stream is separated for forming an H | 04-28-2016 |
Eleftherios Doudousakis, New Rochelle, NY US
Patent application number | Description | Published |
---|---|---|
20100246231 | ACHIEVING ZVS IN A TWO QUADRANT CONVERTER USING A SIMPLIFIED AUXILIARY CIRCUIT - A zero voltage switch half bridge converter comprises a first and second diode series diodes, parallel with a voltage source. A first terminal of an inductor is joined to the diode junction. A first semiconductor auxiliary switch connected in series between the voltage source and a third diode, which is in series with a fourth diode connected to a second semiconductor auxiliary switch. First and second semiconductor main switches are connected in series and in parallel with the voltage supply. A capacitive voltage divider connected across the voltage source, wherein a second terminal of the inductor is connected to junction of the main switches and a midpoint of the capacitive voltage divider. A control circuit is configured to provide respective control signals to at least the first semiconductor auxiliary switch and the second semiconductor auxiliary switch. | 09-30-2010 |
20110140630 | DRIVE CIRCUIT FOR HIGH-BRIGHTNESS LIGHT EMITTING DIODES - A drive circuit includes a DC/DC converter, an outer control loop providing an output voltage representing a comparison between a load current and a reference voltage, a multiplier multiplying the outer control loop output voltage with a sample of the rectified output and provide an output current, a current amplifier comparing an input line current sample and the multiplier output current, a comparator driving the switch with a modulated output based on the current amplifier output and a sawtooth reference, and an upper voltage limit loop having an output in electrical communication with the outer control loop output, wherein the outer control loop output voltage is impacted by the upper voltage limit loop output during a zero load scenario. The drive circuit also includes a line voltage transformer and a lightning suppression circuit coupled to the voltage rectifier output. | 06-16-2011 |
Eleftherios Gdoutos, Pasadena, CA US
Patent application number | Description | Published |
---|---|---|
20130301113 | DEFORMABLE MIRRORS AND METHODS OF MAKING THE SAME - A deformable mirror is configured to be deformed by surface-parallel actuation. In one embodiment, the deformable mirror includes a first piezoelectric active layer on a first surface of a substrate. The first piezoelectric active layer has a substantially uniform thickness across the first surface of the substrate. The mirror also includes a first electrode layer on the first piezoelectric active layer. The first electrode layer has a plurality of electrodes arranged in a first pattern and has a substantially uniform thickness across the first piezoelectric active layer. The mirror may further include a second piezoelectric layer on the first electrode layer, and a second electrode layer on the second piezoelectric layer. The electrodes of the first and second electrode layers are configured to supply a voltage to the piezoelectric active layers upon actuation to thereby locally deform the shape of the mirror to correct for optical aberrations. | 11-14-2013 |
20130302633 | THIN FILM BI-MATERIAL LATTICE STRUCTURES AND METHODS OF MAKING THE SAME - A micro-scaled bi-material lattice structure includes a frame comprising a first material having a first coefficient of expansion and defining a plurality of unit cells. The bi-material lattice structure further includes a plurality of plates comprising a second material having a second coefficient of expansion different from the first coefficient of expansion. One of the plates is connected to each unit cell. The bi-material lattice structure has a third coefficient of expansion different from both the first coefficient of the expansion and the second coefficient of expansion, and the bi-material lattice structure has a thickness of about 100 nm to about 3000 microns. | 11-14-2013 |
Eleftherios Kontopodis, Heraklion GR
Patent application number | Description | Published |
---|---|---|
20160139226 | APPARATUSES, METHODS AND SYSTEMS FOR ESTIMATING WATER DIFFUSIVITY AND MICROCIRCULATION OF BLOOD USING DW-MRI DATA - APPARATUSES, METHODS AND SYSTEMS FOR ESTIMATING WATER DIFFUSIVITY AND MICROCIRCULATION OF BLOOD USING DW-MRI DATA (“AEW”) are disclosed herein. The apparatuses, methods and systems provide a computational framework for choosing and applying the most appropriate model in different regions of a heterogeneous area on a voxel-by-voxel basis. The apparatuses, methods and systems also configure an intravoxel-incoherent-motion (IVIM) model for estimating water diffusivity and microcirculation of blood in the capillary network from DW-MRI low b-value data. In one implementation, the method uses a small number of b-values (at least 3 in the b-value range of 0-300 s/mm | 05-19-2016 |
Eleftherios Kosmidis, Dafni Attikis GR
Patent application number | Description | Published |
---|---|---|
20160081763 | PATHOLOGY LOCALIZER AND THERAPEUTICAL PROCEDURE GUIDE SYSTEM - A pathology localizer and therapeutical procedure guide system comprising an elongate strip ( | 03-24-2016 |
Eleftherios Kougoulos, Morrisville, NC US
Patent application number | Description | Published |
---|---|---|
20120302550 | SALTS AND POLYMORPHS OF 8-FLUORO-2--1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE - The present invention relates to novel polymorphic forms of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro- | 11-29-2012 |
20130310533 | Temperature Controlled Sol-Gel Co-Condensation - Provided according to some embodiments of the invention are methods of making co-condensed macromolecules that include forming a reaction mixture by combining at leak one reactant and at least one reagent at a first temperature at which the at least one reactant is substantially unreactive in the presence of the at least one reagent; raising the temperature of the reaction mixture to a second temperature at which the at least one reactant is reactive in the presence of the at least one reagent, wherein the reaction of the at least one reactant in the presence of the at least one reagent produces co-condensed macromolecules such as co-condensed silica macromolecules. | 11-21-2013 |
20140107071 | METHODS OF MANUFACTURING TOPICAL COMPOSITIONS AND APPARATUS FOR THE SAME - Provided according to some embodiments of the invention are methods of manufacturing a pharmaceutical composition. In some embodiments, such methods include homogenizing at a first excipient composition that includes a viscosity agent and at least one solvent to form a first premix composition; separately homogenizing at least one active pharmaceutical ingredient (API) and a second excipient composition to form a second premix composition; and combining the first premix composition and the second premix composition to form the composition. The pre-mixing of constituents may increase the stability of the API and provide uniformity of the dispersion of the constituents throughout the final topical composition. | 04-17-2014 |
20140141247 | PROCESS FOR THE PREPARATION OF FLUTICASONE PROPIONATE FORM 1 - The invention relates to a novel crystallisation process for preparing fluticasone propionate as crystalline form 1 polymorph with controlled particle size and suitable for micronisation. Said process comprises the step of dissolving fluticasone propionate in acetone or in a mixture of acetone and water and then adding this solution to water or to a mixture of water 10 and acetone, thereby causing fluticasone propionate to crystallise out of the solution as crystalline form | 05-22-2014 |
20140242023 | Topical Compositions and Methods of Using the Same - The present invention relates generally to topical compositions and methods of using the same. | 08-28-2014 |
20140243318 | SALTS AND POLYMORPHS OF 8-FLUORO-2--1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE - The present invention relates to novel polymorphic forms of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one, and to processes for their preparation. Such polymorphic forms may be a component of a pharmaceutical composition and may be used to treat a mammalian disease condition mediated by poly(ADP-ribose) polymerase activity including the disease condition such as cancer. | 08-28-2014 |
20150141606 | TEMPERATURE CONTROLLED SOL-GEL CO-CONDENSATION - Provided according to some embodiments of the invention are methods of making co-condensed macromolecules that include forming a reaction mixture by combining at least one reactant and at least one reagent at a first temperature at which the at least one reactant is substantially unreactive in the presence of the at least one reagent; raising the temperature of the reaction mixture to a second temperature at which the at lest one reactant is reactive in the presence of the at least one reagent, wherein the reaction of the at least one reactant in the presence of the at least one reagent produces co-condensed macromolecules such as co-condensed silica macromolecules. | 05-21-2015 |
20150238504 | SALTS AND POLYMORPHS OF 8-FLUORO-2--1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE - The present invention relates to novel polymorphic forms of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one, and to processes for their preparation. Such polymorphic forms may be a component of a pharmaceutical composition and may be used to treat a mammalian disease condition mediated by poly(ADP-ribose) polymerase activity including the disease condition such as cancer. | 08-27-2015 |
Eleftherios Markou, South Australia AU
Patent application number | Description | Published |
---|---|---|
20110170952 | Irrigation Methods and Systems - A method for irrigating one or more trees in a hardscape location. The method includes creating an aperture through the hardscape and covering the aperture with a cap. The aperture and cap allow hardscape water run-off to flow into the soil underlying the hardscape in the vicinity of roots of the one or more trees. | 07-14-2011 |
Eleftherios Mylonakis, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20130018007 | Modified Saponins for the Treatment of Fungal Infections - Methods of treating a fungal infection in a subject, the method comprising administering to the subject a modified saponin. | 01-17-2013 |
20150182544 | Modified Saponins for the Treatment of Fungal Infections - Methods of treating a fungal infection in a subject, the method comprising administering to the subject a modified saponin. | 07-02-2015 |
Eleftherios Ntouanoglou, Thessaloniki GR
Patent application number | Description | Published |
---|---|---|
20160026353 | IMPLEMENTING MANAGEMENT OF ASSOCIATIONS BETWEEN ORGANIZATION STRUCTURE ELEMENTS - An information management solution is disclosed that overcomes drawbacks associated with the ability of traditional hierarchy structures to support complex organizational structures. The information management solution uniquely implements a two-level entity associating map for depicting relationships between entities of a group of entities. A first level of the two-level entity association map has units is a one-dimensional layer comprising organizational entities and a second level of the two-level entity associating map is a multi-dimensional level comprising organizational entities to which organizational entities of the first level have a direct association. An entity type of any first-level entity is different than an entity type of any second-level entity. | 01-28-2016 |
Eleftherios Sachlos, Hamilton CA
Patent application number | Description | Published |
---|---|---|
20090075382 | FIBRE-REINFORCED SCAFFOLD - The invention provides a fibre-reinforced scaffold for tissue engineering. The scaffold comprises a matrix comprising a biocompatible polymer, the matrix having a, porous structure; and discrete, macroscopic fibres embedded within the matrix, wherein the fibres are oriented such that at least one mechanical property of the scaffold is anisotropic. The invention further relates to fibre-reinforced films and to processes for producing such scaffolds and films. | 03-19-2009 |
20120252697 | TRANSFORMED HUMAN PLURIPOTENT STEM CELLS AND ASSOCIATED METHODS - The present disclosure provides transformed human pluripotent stem cell (t-hPSC). t-hPSCs are not dependent on Oct4 for renewal and survival, however exhibit a sensitivity to reduced levels of the transcription factor Nanog. Also provided are methods of culturing cells for use in a cell-based screening assay comprising placing one or more transformed human pluripotent stem cells into a receptacle and culturing said stem cells in the receptacle to form a monolayer of stem cells without cell overlap. Methods of screening compounds using t-hPSCs are also described. | 10-04-2012 |
20130065887 | Treatment of Cancer with Dopamine Receptor Antagonists - Described are methods of treating a cancer comprising administering to a subject in need thereof an effective amount of a dopamine receptor (DR) antagonist. The DR antagonist may be a phenothiazine derivative, such as thioridazine or chlorpromazine. Optionally, the cancer is acute myeloid leukemia. Also described are methods for identifying subjects with cancer, methods for providing a prognosis for a subjects with cancer and methods for identifying subjects likely to be responsive to therapy with DR receptor antagonists. Methods for identifying cancer stem cells and chemotherapeutic compounds that are DR receptor antagonists as also provided. Also described are methods for the identification and validation of agents that target cancer stem cells. | 03-14-2013 |
20130261074 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER - Described are methods and compositions for treating cancer that include a dopamine receptor (DR) antagonist such as thioridazine and a chemotherapeutic agent. Optionally, the chemotherapeutic agent is a DNA synthesis inhibitor such as cytarabine or a microtubule inhibitor such as paclitaxel or docetaxel. The methods and compositions are useful for the treatment of cancers such as acute myeloid leukemia. | 10-03-2013 |
20130331381 | Treatment of Cancer WIth Dopamine Receptor Antagonists - Described are methods of treating a cancer comprising administering to a subject in need thereof an effective amount of a dopamine receptor (DR) antagonist. The DR antagonist may be a phenothiazine derivative, such as thioridazine or chlorpromazine. Optionally, the cancer is acute myeloid leukemia. Also described are methods for identifying subjects with cancer, methods for providing a prognosis for a subjects with cancer and/or subjects likely to be responsive to therapy with DR receptor antagonists. Methods for identifying cancer stem cells and chemotherapeutic compounds that are DR receptor antagonists as also provided. | 12-12-2013 |
20150038371 | TRANSFORMED HUMAN PLURIPOTENT STEM CELLS AND ASSOCIATED METHODS - The present disclosure provides transformed human pluripotent stem cell (t-hPSC). t-hPSCs are not dependent on Oct4 for renewal and survival, however exhibit a sensitivity to reduced levels of the transcription factor Nanog. Also provided are methods of culturing cells for use in a cell-based screening assay comprising placing one or more transformed human pluripotent stem cells into a receptacle and culturing said stem cells in the receptacle to form a monolayer of stem cells without cell overlap. Methods of screening compounds using t-hPSCs are also described. | 02-05-2015 |
20150038450 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER - Described are methods and compositions for treating cancer that include a dopamine receptor (DR) antagonist such as thioridazine and a chemotherapeutic agent. Optionally, the chemotherapeutic agent is a DNA synthesis inhibitor such as cytarabine or a microtubule inhibitor such as paclitaxel or docetaxel. The methods and compositions are useful for the treatment of cancers such as acute myeloid leukemia. | 02-05-2015 |
Eleftherios Schoinas US
Patent application number | Description | Published |
---|---|---|
20150377495 | METHOD FOR AUTONOMOUS OPERATION OF RADIATOR AND APPLIANCE MICROBOILER - A method for autonomous operation of a radiator and the appliance microboiler, independently and without its removal or disconnection from the heating installation, giving the possibility to operation as single radiator or alternatively within the system where it is installed. The microboiler appliance ( | 12-31-2015 |
Eleftherios Schoinas, Rethymno, Crete GR
Patent application number | Description | Published |
---|---|---|
20150377495 | METHOD FOR AUTONOMOUS OPERATION OF RADIATOR AND APPLIANCE MICROBOILER - A method for autonomous operation of a radiator and the appliance microboiler, independently and without its removal or disconnection from the heating installation, giving the possibility to operation as single radiator or alternatively within the system where it is installed. The microboiler appliance ( | 12-31-2015 |